GSK Consumer profit drops 17.5% to Rs132.23 crore
GlaxoSmithkline Consumer’s net sales from operations fall to Rs1,045.88 crore in June quarter from Rs1,059.38 crore a year earlier
New Delhi: GlaxoSmithkline Consumer Healthcare Ltd, the maker of Horlicks and Boost health foods, on Tuesday reported a 17.5% drop in net profit for the quarter ended 30 June 2017 as sales dipped by 1.3%.
The dip in sales, according to the company’s statement, was “mainly on account of CSD (Canteen Store Department) consumption loss and destocking of wholesale channels as trade sentiments remained cautious due to Goods and Services Tax (GST) implementation”.
“This led to softer consumption and reduced trade pipelines, yet, the company managed to remain the market leader in the health food drinks category,” it added.
Net profit dropped to Rs132.23 crore in the quarter ended 30 June from Rs160.61 crore a year earlier. Net sales from operations fell to Rs1,045.88 crore in the quarter from Rs1,059.38 crore a year earlier.
“The overall business environment remained tepid during the quarter largely on the account of destocking of goods in wholesale channels and CSD consumption loss ahead of GST implementation. We continue to drive brand building initiatives through stepped up investments in our brands, innovations and consumer-connect activities. With good predicted monsoons, we are optimistic about the coming quarters,” Manoj Kumar, managing director, GSK Consumer Healthcare said in a statement.
Editor's Picks »
- With fall of the last dove, MPC minutes portend more than one RBI rate hike
- RITES IPO ticks the valuations box, but not the growth one
- Is Reliance Jio really India’s most profitable telecom firm?
- How US-China trade war will affect India
- Dear ICICI Bank board, giving a red card to Chanda Kochhar is not enough